biospecimen__admin__batch_number	399.48.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	18E5985A-4555-4219-ADD5-7EB9366C110B
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-UB-AA0U-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-UB-AA0U-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-UB-AA0U-01A
biospecimen__bio__biospecimen_barcode_bottom	0164104762
biospecimen__bio__day_of_creation	24
biospecimen__bio__day_of_shipment	26
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-UB-AA0U.00C0CD33-615E-47A6-8CEF-EE3A67F277D3.pdf
biospecimen__bio__plate_column	11
biospecimen__bio__plate_id	A38M
biospecimen__bio__plate_row	D
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-UB-AA0U
biospecimen__shared__patient_id	AA0U
clinical__ablation__ablation_performed_indicator	NO
clinical__ablation__ablation_type	Radiofrequency Ablation
clinical__ablation__bcr_ablation_barcode	TCGA-UB-AA0U-A67167
clinical__ablation__bcr_ablation_uuid	22C851AD-089C-49DA-8125-1D131A0ACF03
clinical__ablation__days_to_ablation_performed	326
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_therapy_drug_name	Doxorubicin
clinical__ablation__embolization_type	Chemoembolization
clinical__ablation__embolizing_agent_utilized	Other, specify
clinical__ablation__embolizing_agent_utilized_other	Ethiodol
clinical__ablation__lesions_count	1
clinical__ablation__treatment_cycles_count	3
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	3684E98E-72C5-4F08-ACD8-90950C49F94F
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	3.9
clinical__chol_lihc_shared__albumin_result_upper_limit	4.8
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	0.7
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.7
clinical__chol_lihc_shared__creatinine_upper_limit	1.2
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.6
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	8
clinical__chol_lihc_shared__fetoprotein_outcome_value	26
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Non-Alcoholic Fatty Liver Disease
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.2
clinical__chol_lihc_shared__platelet_result_lower_limit	140
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	1.1
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Single
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.3
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	60
clinical__clin_shared__bcr_followup_barcode	TCGA-UB-AA0U-F67166
clinical__clin_shared__bcr_followup_uuid	6C743EC2-C280-435C-B1C3-319361ADA9E7
clinical__clin_shared__cancer_first_degree_relative	2
clinical__clin_shared__day_of_form_completion	16
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	10
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	227
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R1
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis  C Antibody
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	NO
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	106
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	5606c9e3-6a25-4e2b-b5d8-c799eeb2f2a5
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-UB-AA0U-01A-11R-A38M-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	d07243d8-79f4-4fc4-a2bc-157aebdb632a
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.85
gdc__analytes__analyte_id	5b60fa4a-93e7-41e8-a597-b6f48879b7fb
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	ae8d4b34-d40a-482d-9d45-23242843df00
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:32:47.609868-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	93208168-cbd2-5570-b9d5-2c76375534bd
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1953
gdc__diagnoses__age_at_diagnosis	21985
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-21985.0
gdc__diagnoses__days_to_last_follow_up	327.0
gdc__diagnoses__diagnosis_id	5fe77a91-b880-56bf-b485-ee4a18082fcf
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	29.352354500694357
gdc__exposures__exposure_id	604f6ca5-0eb1-5cd1-9663-fc48aa62c929
gdc__exposures__height	178.0
gdc__exposures__weight	93.0
gdc__file_id	83e681a8-b7f6-43ef-966d-c0117a3cdd3d
gdc__file_name	d8cb4b80-dee8-492f-85f1-80d057bb8491.mirbase21.mirnas.quantification.txt
gdc__file_size	50309
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	a03dcb8739841bb7e7229e551329e8b1
gdc__portions__is_ffpe	false
gdc__portions__portion_id	a51aa4dd-7385-4167-8669-a821172175fc
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	18
gdc__samples__initial_weight	730.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	00C0CD33-615E-47A6-8CEF-EE3A67F277D3
gdc__samples__sample_id	e1af89c8-f9ab-4599-a1f5-c7145d40378e
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	70.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	36c19145-d6e8-44d2-a575-94fac7066789
gdc__submitter_id	mirna_swap_dr11_168_MirnaExpression9bee2295-2659-401f-913c-ba9b5533fb7c_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	UB
gdc__tissue_source_site__name	UCSF
gdc__tissue_source_site__tissue_source_site_id	2a8f962a-d2a8-5fb6-aea0-6bf694c0769c
gdc__treatments__treatment_id	69cd6ef5-3ec7-51d1-81d8-7edfa3b68734
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:08:35.061+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/5606c9e3-6a25-4e2b-b5d8-c799eeb2f2a5-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/5606c9e3-6a25-4e2b-b5d8-c799eeb2f2a5-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129680
manually_curated__local_md5	d70b4d5a5603386a68c6bc1238ae0055
manually_curated__opengdc_download_date	2018-10-16T17:10:54.000478+02:00
manually_curated__opengdc_file_md5	bc43b0226dbd0d8e07e4c6e39af35296
manually_curated__opengdc_file_size	50308
manually_curated__opengdc_id	5606c9e3-6a25-4e2b-b5d8-c799eeb2f2a5-meq
manually_curated__origin_file_size	129680
manually_curated__origin_last_modified_date	Tue Oct 16 17:53:00 CEST 2018
manually_curated__origin_md5	d70b4d5a5603386a68c6bc1238ae0055
manually_curated__tissue_status	tumoral
